Metformin Dysregulates the Unfolded Protein Response and the WNT/β-Catenin Pathway in Endometrial Cancer Cells through an AMPK-Independent Mechanism
Multiple lines of evidence suggest that metformin, an antidiabetic drug, exerts anti-tumorigenic effects in different types of cancer. Metformin has been reported to affect cancer cells’ metabolism and proliferation mainly through the activation of AMP-activated protein kinase (AMPK). Here, we show...
Glavni autori: | Domenico Conza, Paola Mirra, Gaetano Calì, Luigi Insabato, Francesca Fiory, Francesco Beguinot, Luca Ulianich |
---|---|
Format: | Članak |
Jezik: | English |
Izdano: |
MDPI AG
2021-04-01
|
Serija: | Cells |
Teme: | |
Online pristup: | https://www.mdpi.com/2073-4409/10/5/1067 |
Slični predmeti
-
Metformin: A New Inhibitor of the Wnt Signaling Pathway in Cancer
od: Domenico Conza, i dr.
Izdano: (2023-08-01) -
Overview of Wnt/β-Catenin Pathway and DNA Damage/Repair in Cancer
od: Silvina B. Nadin, i dr.
Izdano: (2025-02-01) -
Sevoflurane inhibits cholangiocarcinoma via Wnt/β-catenin signaling pathway
od: Hui Cheng, i dr.
Izdano: (2023-08-01) -
Metformin ameliorates peripheral neuropathy in diabetic rats by downregulating autophagy via the AMPK pathway
od: Fangqin You, i dr.
Izdano: (2025-01-01) -
Metformin induces tumor immunogenic cell death in ovarian cancer by activating AMPK pathway
od: Yixiong Chen, i dr.
Izdano: (2024-09-01)